Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹329 Cr.
Stock P/E
36.5
P/B
3.1
Current Price
₹170.1
Book Value
₹ 55.3
Face Value
10
52W High
₹216.8
52W Low
₹ 69
Dividend Yield
0.29%

QMS Medi Allied Ser. Overview

Business

QMS Medical Allied Services Ltd. is an Indian company primarily involved in the trading, distribution, and marketing of a diverse range of medical devices, equipment, and allied healthcare products. The company sources products from various domestic and international manufacturers and distributes them to a broad customer base, including hospitals, clinics, diagnostic centers, and other healthcare institutions across India. Its core business model revolves around generating revenue from sales margins on these medical products, often supplemented by offering installation, maintenance, and after-sales support services.

Revenue Mix

The company's primary revenue stream is derived from the trading and distribution of medical devices and equipment. While specific breakdown percentages are not publicly detailed without access to financial reports, it is inferred that the revenue mix is heavily concentrated on product sales. Their offerings likely span various medical specialties such as diagnostic imaging, critical care, surgical instruments, and general hospital equipment. Any service revenue (installation, maintenance, support) would typically constitute a smaller, yet important, component of the overall revenue mix.

Industry

QMS Medical Allied Services operates within the dynamic and growing Indian medical device market, which is characterized by fragmentation. The industry includes large multinational manufacturers with direct sales operations, as well as numerous domestic manufacturers and a multitude of distributors. As a trading and distribution company, QMSMEDI positions itself as a critical intermediary, leveraging its sales network and relationships with healthcare providers to deliver products from manufacturers to end-users. Its competitive standing relies on its ability to secure distribution rights for quality products, offer competitive pricing, and provide reliable logistics and after-sales service, competing with other regional and national distributors.

MOAT

QMS Medical Allied Services Ltd. likely possesses a relatively limited economic moat typical of pure-play trading businesses. Potential competitive advantages may include:

Established Distribution Network: A well-developed sales and logistics network enabling reach across various Indian geographies and customer segments.

Supplier Relationships: Long-standing or exclusive distribution agreements with specific, reputable medical device manufacturers, offering access to their product portfolios.

Customer Relationships: Deep-rooted relationships with hospitals, clinics, and key decision-makers within the healthcare sector built over time.

However, these advantages can be vulnerable to new market entrants, changes in manufacturer strategies (e.g., shifting to direct sales), or intense price competition from other distributors.

Growth Drivers

Key factors that could drive growth for QMS Medical Allied Services Ltd. over the next 3-5 years include:

Increasing Healthcare Expenditure: Continued rise in both public and private spending on healthcare infrastructure and services in India.

Growing Demand for Medical Devices: Higher demand for advanced medical equipment driven by improving healthcare access, rising awareness, and demographic changes.

Product Portfolio Expansion: Adding new and innovative medical devices, technologies, or specialized product lines to its existing catalog.

Geographic Market Penetration: Expanding its reach into new regional markets within India or deepening its presence in existing high-growth areas.

Strategic Partnerships: Securing new or exclusive distribution agreements with leading global and domestic medical device manufacturers.

Risks

Intense Competition: Significant competition from other domestic distributors, as well as direct sales channels of large multinational manufacturers.

Supplier Dependency: Reliance on a few key manufacturers for product supply; loss or unfavorable changes in distribution contracts could impact revenue.

Regulatory & Policy Changes: Adverse changes in government policies, import duties, pricing controls for medical devices, or healthcare regulations in India.

Technological Obsolescence: Rapid advancements in medical technology necessitating continuous adaptation of product offerings and inventory management.

Working Capital Management: Challenges in efficiently managing inventory levels and receivables, which is crucial for profitability in a trading business.

Currency Fluctuations: As an importer of medical devices, unfavorable foreign exchange rate movements can increase procurement costs and impact margins.

Management & Ownership

QMS Medical Allied Services Ltd. is characteristic of many small-to-mid-cap Indian companies, likely being promoter-driven. Promoters typically hold a substantial ownership stake, which can foster long-term alignment between their interests and the company's growth objectives. The management team is expected to comprise professionals with experience in the medical device distribution sector, possessing knowledge of the Indian healthcare market, sales, and logistics. Specific details regarding the quality of management and the exact ownership structure would require a review of their latest annual reports and public disclosures.

Outlook

QMS Medical Allied Services Ltd. operates within the robustly expanding Indian healthcare sector, which offers a favorable environment for growth in medical device demand. The company's future performance will largely depend on its execution capabilities, including its ability to secure and maintain strong relationships with both suppliers and healthcare customers, effectively expand its product portfolio, and optimize its distribution network. While the underlying market trends are positive, the company faces inherent challenges such as intense competition, potential supply chain disruptions, and pricing pressures that could impact profitability. Prudent financial management, particularly working capital, and agility in adapting to regulatory and technological changes will be critical for sustained success.

QMS Medi Allied Ser. Share Price

Live · NSE · Inception: 2017
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

QMS Medi Allied Ser. Quarterly Results

#(Fig in Cr.) Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023
Net Sales 25 27 21 31 26
Other Income 0 0 0 0 0
Total Income 25 28 21 32 26
Total Expenditure 23 25 17 28 21
Operating Profit 2 3 4 3 5
Interest 1 1 0 1 1
Depreciation 0 0 0 0 1
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 1 2 3 2 3
Provision for Tax 0 1 1 1 1
Profit After Tax 1 2 3 2 2
Adjustments 0 -0 0 0 0
Profit After Adjustments 1 2 3 2 2
Adjusted Earnings Per Share 0.4 1.1 1.4 0.9 1.4

QMS Medi Allied Ser. Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 52 73 122 146 104 122 105
Other Income 0 0 0 1 1 0 0
Total Income 52 73 122 148 105 123 107
Total Expenditure 47 63 105 130 93 104 91
Operating Profit 5 10 17 18 12 19 15
Interest 0 1 1 2 2 3 3
Depreciation 0 0 1 1 1 3 1
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax 4 9 15 14 9 12 10
Provision for Tax 1 2 4 4 2 3 4
Profit After Tax 3 6 11 11 6 9 9
Adjustments 0 0 0 0 0 0 0
Profit After Adjustments 3 6 11 11 6 9 9
Adjusted Earnings Per Share 2 4.2 7.3 7.1 3.6 5 4.8

QMS Medi Allied Ser. Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 3 9 20 31 70 79
Minority's Interest 0 0 0 0 0 0
Borrowings 0 0 1 2 1 2
Other Non-Current Liabilities -0 -0 0 0 0 0
Total Current Liabilities 15 24 39 52 46 56
Total Liabilities 18 33 60 85 118 137
Fixed Assets 0 3 10 8 25 24
Other Non-Current Assets 0 0 0 0 5 6
Total Current Assets 18 30 50 77 88 107
Total Assets 18 33 60 85 118 137

QMS Medi Allied Ser. Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 0 0 1 1 2 1
Cash Flow from Operating Activities -4 -3 2 -2 -8 1
Cash Flow from Investing Activities -0 -4 -8 2 -25 -3
Cash Flow from Financing Activities 5 7 7 0 32 0
Net Cash Inflow / Outflow 0 1 1 1 -1 -1
Closing Cash & Cash Equivalent 0 1 1 2 1 0

QMS Medi Allied Ser. Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 2.02 4.22 7.25 7.1 3.57 5.04
CEPS(Rs) 2.04 4.46 7.74 7.87 4.17 6.97
DPS(Rs) 0 0 0 0 0.5 0.5
Book NAV/Share(Rs) 2.03 6.25 13.5 20.62 39.44 43.99
Core EBITDA Margin(%) 8.96 13.2 13.93 11.37 10.89 15.02
EBIT Margin(%) 8.92 12.76 13.37 11.55 10.57 12.58
Pre Tax Margin(%) 8.43 11.99 12.21 9.88 8.37 10.02
PAT Margin (%) 5.85 8.74 8.95 7.3 6.13 7.37
Cash Profit Margin (%) 5.92 9.23 9.55 8.1 7.16 10.19
ROA(%) 16.97 24.76 23.27 14.7 6.27 7.05
ROE(%) 99.46 102.03 73.44 41.62 12.58 12.09
ROCE(%) 60.89 64.85 53.55 32.83 13.83 14.7
Receivable days 56.39 48.25 51.14 81.1 142.24 120.2
Inventory Days 62.98 61.84 53.84 55.58 95.04 100.89
Payable days 79.4 69.29 59.68 58.07 84.96 89.36
PER(x) 0 0 0 0 36.16 22.94
Price/Book(x) 0 0 0 0 3.28 2.63
Dividend Yield(%) 0 0 0 0 0.38 0.43
EV/Net Sales(x) 0.09 0.19 0.18 0.23 2.46 1.99
EV/Core EBITDA(x) 0.95 1.45 1.29 1.86 21.26 12.93
Net Sales Growth(%) 0 40.17 67.77 19.9 -28.9 17.38
EBIT Growth(%) 0 100.39 75.82 3.55 -34.93 39.74
PAT Growth(%) 0 109.43 71.72 -2.11 -40.32 41.14
EPS Growth(%) 0 109.43 71.72 -2.11 -49.68 41.14
Debt/Equity(x) 1.49 1.23 0.96 1.03 0.36 0.44
Current Ratio(x) 1.2 1.25 1.28 1.48 1.9 1.93
Quick Ratio(x) 0.63 0.6 0.76 1.01 1.25 1.26
Interest Cover(x) 18.06 16.6 11.58 6.93 4.81 4.91
Total Debt/Mcap(x) 0 0 0 0 0.11 0.17

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +17% 0% +19% —
Operating Profit CAGR +58% +4% +31% —
PAT CAGR +50% -6% +25% —
Share Price CAGR +69% +4% — —
ROE Average +12% +22% +48% +57%
ROCE Average +15% +20% +36% +40%

QMS Medi Allied Ser. Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 68.11 %
FII 0 %
DII (MF + Insurance) 1.59 %
Public (retail) 30.3 %
# Dec 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Jun 2025 Sep 2025 Mar 2026 Jun 2026
Promoter 73.6773.6773.6773.6773.6773.6773.6768.1168.1168.11
FII 0.711.211.020.010.010.010.010.0100
DII 00000001.61.591.59
Public 25.6325.1225.3126.3326.3326.3326.3330.2830.330.3
Others 0000000000
Total 100100100100100100100100100100

QMS Medi Allied Ser. Peer Comparison

QMS Medi Allied Ser. Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

QMS Medi Allied Ser. Pros & Cons

Pros

  • Company has delivered good profit growth of 24% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 22%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 84.96 to 89.36days.
  • Stock is trading at 3.1 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp